Search

everythinglearnresearchcommunity

for

Search:↓

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

TS-13 effectively stops tumor growth and reduces chemotherapy side effects.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

CTIP2 may help in skin development and maintenance.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

A specific enzyme that activates the hair growth medication minoxidil when applied to the skin was identified.

Butin is effective in treating vitiligo in mice.

The document corrects a mistake by stating that pimecrolimus, not tacrolimus, is the drug that concentrates in the skin.

Neurotrophin-4 increases calcium current in specific mouse neurons through the PI3K pathway.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

A new compound effectively inhibits human 5α-reductase 1.

Retinoids can help treat skin pigmentation disorders by affecting melanin production.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

TRIV-509 quickly improves skin barrier and cell health in atopic dermatitis.

The microneedle patches effectively treat allergic conjunctivitis with controlled, sustained release of medication.

Tributyltin exposure causes sex changes, sterilization, and decline in the snail Ocinebrina aciculata, risking its extinction.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

PTEN helps control the number and health of skin stem cells by working with the protein BMAL1.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

Newly designed proteins can effectively degrade specific proteins in cells, offering a potential new therapy method.

Melatonin stops melanin production after tyrosinase action, with cyclic GMP mimicking this effect.

TIP39 and PTH2R help control calcium levels and skin cell development.

A new microneedle patch effectively promotes hair regrowth with less frequent dosing.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Timosaponin BII, a plant extract, was found to promote hair growth in mice, similarly to minoxidil.

ODC expression in mouse skin and tumors is varied and can be inhibited by retinoic acid or cycloheximide.